A world, April 10 -- first trial will see researchers from Australia's Austin Health and the University of Melbourne, use intravenous zinc to fight the symptoms of coronavirus (COVID-19).

The trial will be led by Austin Health's Dr Joseph Ischia and Dr Oneel Patel from the Department of Surgery at the University of Melbourne, who has a long history of investigating the protective effects of intravenous zinc against organ damage induced by lack of oxygen.

Dr Ischia, said COVID-19 is especially dangerous because it replicates inside a patient's body which can lead to respiratory conditions like bronchitis and pneumonia.

"If COVID-19 enters a patient's lungs then they often need to be placed on a ventilator to help their breathing and, in...